Identifying new E3 Ubiquitin ligase ligands for new PROTACs design is a key element that can improve selective proteasomal-dependent degradation of proteins of interest involved in many pathological processes such as cancer, chronic anaemia, and ischemia.

Our fluorescent probes for VHL and CRBN E3 ligase are powerful tools both for compound screening for new E3ligase ligands and for PROTACs analysis, suitable for in vitro microscopy, binding assays such as TR-FRET competition assays.

Do you want more information?

We are ready to support your challenges